Itaconix said on Friday that first-half revenue rose to a record $8.3m, up 72% from a year earlier, prompting the plant-based specialty polymers group to raise its full-year sales outlook above market expectations.
Itaconix
17 July 2026 09:10:04
Source: Sharecast
Growth was driven across all major product segments, with strong demand from existing customers and new detergent customers in Europe and North America, while the gross profit margin is expected to remain in line with 2025 at 36%.
The AIM-traded company now expects FY26 revenue of at least $14.8m, ahead of current analyst forecasts of $13.3m, while continuing to target a small positive EBITDA despite ongoing investment in product development and headcount.
Itaconix said it was also progressing longer-term growth opportunities for its BIO*Asterix specialty monomers and binders in paints and its BioVail plant nutrition ingredient for agriculture.
At 0849 BST, shares in Itaconix were up 18.72% at 139.5p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
